Research article
Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis
Arthritis Research & Therapy 2012, 14:R150 doi:10.1186/ar3886
No comments have yet been made on this article.
